Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Current Assets (2017 - 2022)

Historic Current Assets for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $66.7 million.

  • Iterum Therapeutics' Current Assets fell 2611.71% to $66.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $66.7 million, marking a year-over-year decrease of 2611.71%. This contributed to the annual value of $83.3 million for FY2021, which is 28778.87% up from last year.
  • According to the latest figures from Q3 2022, Iterum Therapeutics' Current Assets is $66.7 million, which was down 2611.71% from $70.9 million recorded in Q2 2022.
  • Over the past 5 years, Iterum Therapeutics' Current Assets peaked at $141.7 million during Q2 2018, and registered a low of $11.7 million during Q4 2019.
  • Moreover, its 5-year median value for Current Assets was $73.7 million (2022), whereas its average is $66.7 million.
  • Per our database at Business Quant, Iterum Therapeutics' Current Assets tumbled by 8739.61% in 2019 and then soared by 64809.69% in 2021.
  • Over the past 5 years, Iterum Therapeutics' Current Assets (Quarter) stood at $93.0 million in 2018, then plummeted by 87.4% to $11.7 million in 2019, then soared by 83.24% to $21.5 million in 2020, then skyrocketed by 287.79% to $83.3 million in 2021, then dropped by 19.95% to $66.7 million in 2022.
  • Its Current Assets was $66.7 million in Q3 2022, compared to $70.9 million in Q2 2022 and $76.4 million in Q1 2022.